LongevityResearch Phase

Sirtuin-Activating Peptides

Subcutaneous injection

Overview

Sirtuin-activating peptides represent a class of investigational compounds designed to enhance the enzymatic activity of sirtuins, a family of NAD-dependent deacetylases implicated in longevity and metabolic regulation. These peptides aim to mimic or potentiate the effects of caloric restriction by modulating histone deacetylation, mitochondrial biogenesis, and stress resistance pathways.

Mechanism of Action

While small molecule sirtuin activators such as resveratrol analogues have received more research attention, peptide-based approaches remain in early discovery phases. The therapeutic rationale centers on reproducing the lifespan-extending effects of sirtuin overexpression observed in lower organisms..

Research Summary & Key Findings

Most evidence for sirtuin activation and longevity derives from studies using genetic manipulation or small molecule activators in yeast, worms, and mice rather than peptide therapeutics. Peptide-based sirtuin modulators have been characterized in vitro and in preliminary rodent studies, but no clinical trials have evaluated safety or efficacy in humans. The translation of sirtuin biology to human aging interventions remains an active area of investigation without conclusive clinical proof of concept.

Clinical Status

Research Phase

Sirtuin-Activating Peptides is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.

Administration Routes

Subcutaneous injection

Related Peptides in Longevity

Find a Provider

Find a verified provider who offers Sirtuin-Activating Peptides therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Sirtuin-Activating Peptides.

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.